Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Examining the Role of Aberrant Myelopoiesis in Cancer Cachexia Development
EF 2023-24
Résumé
Cancer cachexia, a multifactorial syndrome which can be characterized by the continuous loss of skeletal muscle mass and adipose tissue as well as the presence of chronic inflammation, is diagnosed in 50-80% of cancer patients and is the direct cause of 20-40% of cancer mortality. Increases in myeloid lineage-derived inflammatory cells and pro-inflammatory cytokines such as IL-1, IL-6, IL-8, and TNF-alpha, are evident in the blood and skeletal muscles of individuals with cancer cachexia, coinciding with muscle atrophy and lipolysis. This evidence suggests that alterations to hematopoietic stem cell differentiation resulting in aberrant myelopoiesis occurs in cancer cachexia. It remains unknown; however, whether aberrant myelopoiesis is an initiating event in cancer cachexia. Therefore, the objective of this study is to determine the temporal relationship between aberrant myelopoiesis and the development of cancer cachexia. We hypothesize that alterations to the hematopoietic stem cell differentiation driven by changes in their microenvironment will occur prior to cachexia and, that myeloid skewing will intensify with cancer cachexia progression. We will use a Lewis lung carcinoma mouse model to induce cachexia and analyze the bone marrow cellular composition using a flow cytometer across the time course of cachexia development and progression. This research aims to discover the cellular initiation of cancer cachexia as well as contribute to the understanding of cancer cachexia's immunopathogenesis. These findings are expected to provide a basis for new diagnostic measures and cellular targets to aid in the prevention, recognition, and treatment of cancer cachexia.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506173
Name
Tate Alice A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Examining the Role of Aberrant Myelopoiesis in Cancer Cachexia Development
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aberrant Myelopoiesis; Bone Marrow; Cancer Cachexia; Hematopoiesis; Hematopoietic Stem Cells; Myelopoiesis
Abstract
Cancer cachexia, a multifactorial syndrome which can be characterized by the continuous loss of skeletal muscle mass and adipose tissue as well as the presence of chronic inflammation, is diagnosed in 50-80% of cancer patients and is the direct cause of 20-40% of cancer mortality. Increases in myeloid lineage-derived inflammatory cells and pro-inflammatory cytokines such as IL-1, IL-6, IL-8, and TNF-alpha, are evident in the blood and skeletal muscles of individuals with cancer cachexia, coinciding with muscle atrophy and lipolysis. This evidence suggests that alterations to hematopoietic stem cell differentiation resulting in aberrant myelopoiesis occurs in cancer cachexia. It remains unknown; however, whether aberrant myelopoiesis is an initiating event in cancer cachexia. Therefore, the objective of this study is to determine the temporal relationship between aberrant myelopoiesis and the development of cancer cachexia. We hypothesize that alterations to the hematopoietic stem cell differentiation driven by changes in their microenvironment will occur prior to cachexia and, that myeloid skewing will intensify with cancer cachexia progression. We will use a Lewis lung carcinoma mouse model to induce cachexia and analyze the bone marrow cellular composition using a flow cytometer across the time course of cachexia development and progression. This research aims to discover the cellular initiation of cancer cachexia as well as contribute to the understanding of cancer cachexia's immunopathogenesis. These findings are expected to provide a basis for new diagnostic measures and cellular targets to aid in the prevention, recognition, and treatment of cancer cachexia.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tate, Alice A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~